AN2 THERAPEUTICS INC (ANTX) Stock Cash Flow
NASDAQ:ANTX - Nasdaq - US0373261058 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -45.35M | -51.32M | -64.73M | -40.96M | -21.54M | |||
| Change In Working Capital | -2.30M | -3.00M | 5.83M | 3.72M | 30.00K | |||
| Other non cash items | 5.37M | 5.06M | 5.61M | 3.78M | 1.03M | |||
| OPERATING CASH FLOW | -42.29M | -49.26M | -53.29M | -33.46M | -20.48M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | 37.49M | 54.59M | -43.28M | -21.77M | -50.02M | |||
| INVESTING CASH FLOW | 37.49M | 54.59M | -43.28M | -21.77M | -50.02M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 88.00K | 372.00K | 84.99M | 70.36M | 79.75M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -1.21M | |||
| FINANCING CASH FLOW | 88.00K | 372.00K | 84.99M | 70.36M | 78.54M | |||
| CHANGE IN CASH | -4.71M | 5.70M | -11.57M | 15.13M | 8.04M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -42.29M | -49.26M | -53.29M | -33.46M | -20.48M | |||
| FREE CASH FLOW | -42.29M | -49.26M | -53.29M | -33.46M | -20.48M | |||
All data in USD